Inconsistencies have also been found in kidney cancer—two independent meta-analyses showed different results: a significant effect of PTEN levels on tumor progression [18] and a low predictive value [19] in renal cell carcinoma (RCC) patients. Here, PTEN is linked to neoplasm.